Recent Headlines
Within Biotechnology

MiTeGen Announces Collaboration and License Agreements with EMBL

MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed agreements with EMBLEM, the commercial subsidiary of the EMBL (the... - May 23, 2013 - MiTeGen, LLC

Lessons from the Fukushima Nuclear Plant Crisis

Dr. Julie Pullen of Stevens Institute of Technology is an expert in modeling chemical, biological, and radiological dispersion in coastal cities. The Bulletin of the American Meteorological Society has published her analysis of the response to the Fukushima Nuclear Plant Crisis. - May 23, 2013 - Stevens Institute of Technology

ALPCO to Exhibit with BÜHLMANN Laboratories at DDW 2013 and Feature Fecal Calprotectin ELISA

The partnering companies will feature BÜHLMANN's Fecal Calprotectin ELISA that is pending FDA clearance for IVD use in the United States. - May 16, 2013 - ALPCO

Colorado Bioscience Association Applauds Signing of The Colorado Advanced Industries Acceleration Act (HB 1001) by Gov. John Hickenlooper

Colorado BioScience Association (CBSA) applauds the signing of The Colorado Advanced Industries Acceleration Act by Gov. John Hickenlooper. The legislation is designed to grow all the high-tech sectors in Colorado: Advanced Manufacturing, Aerospace, Bioscience, Electronics, Energy & Natural Resources, Engineering and Information Technology. - May 16, 2013 - Colorado BioScience Association

Md Stem Cells Continues Billion Cell Treatments for Eye Disease

MD Stem Cells Reports Billion Cell Harvests for Eye Stem Cell Treatments in Florida. - May 11, 2013 - MD Stem Cells

Logos Biosystems Launches the Luna-FLTM Fluorescence Cell Counter

Logos Biosystems, a provider of innovative life science research tools, today announced the introduction of a next generation automated cell counter, the Luna-FL TM. The "Luna-FLTM fluorescence cell counter is a breakthrough for life science researchers," says Neon Jung, CEO of Logos... - May 10, 2013 - Logos Biosystems, Inc

OsoBio Appoints David M. Lee Vice President of Quality

OsoBio has named David M. Lee vice president of quality. Lee is responsible for overseeing all quality-related functions to ensure the company’s continued compliance with Current Good Manufacturing Practices (cGMP), including quality systems, quality control and manufacturing quality... - May 10, 2013 - OSO BioPharmaceuticals Manufacturing, LLC

Pipette.com Enhances User Experience with Site Re-launch Concentrating on Pipettes, Pipette Tips and ISO 17015 Pipette Calibration Service

Leading distributor of pipettes to clients worldwide, Pipette.com has re-launched their popular website. The new website improves visitor’s navigation experience and ensures that users gain access to additional resources that will help guide them in making the best product selection for their... - May 10, 2013 - Pipette.com

Creative BioMart Funded Research Found Another Anticancer Strategy - Targeting Cyclin D

Researchers successfully silenced abnormal proteins that control cells' growth cycle. - May 10, 2013 - Creative Biomart

ALPCO Adds FDA Registered Renin RIA from Cisbio to Product Offering

ALPCO now offering a line of RIA products from Cisbio in the United States. - May 07, 2013 - ALPCO

Bioo Scientific Launches First Kit for Molecular Indexing in RNA-Seq

Bioo Scientific introduces the NEXTflex™ qRNA-Seq™ Kit for high precision gene expression analysis by RNA-Seq. Developed in conjunction with Cellular Research Inc., this new kit efficiently generates libraries equivalent to conventional RNA-Seq libraries, but with the added feature of... - May 07, 2013 - Bioo Scientific

Colorado BioScience Association Names Derek Cole Board Chair and Appoints Six Industry Leaders to its Board of Directors at the 2013 Annual All-Member Meeting

Colorado BioScience Association (CBSA) announces Derek Cole, President of Investor Relations Advisory Solutions, as the new Chairperson of its Board of Directors. Cole assumes chairperson responsibilities from Steve Orndorff, President & CEO of Ariel Pharmaceuticals. In other recent action, six new members were named to the CBSA Board of Directors. - May 04, 2013 - Colorado BioScience Association

ALPCO Launches Human Osteopontin ELISA

ALPCO launches the first assay in a new line of species-specific Osteopontin ELISAs. - May 01, 2013 - ALPCO

ALPCO Expands Product Offering with EuroFlow™ Flow Cytometry Reagents and Infinicyt™ Analytical Software from Cytognos S.L.

Starting April 30, 2013 ALPCO will begin offering flow cytometry solutions from Cytognos S.L. - April 30, 2013 - ALPCO

ALPCO Launches Their First STELLUX Chemiluminescent ELISA

ALPCO announces the launch of their STELLUX Rodent Insulin ELISA, the first ELISA launched in their new STELLUX Chemiluminescent assay product line. - April 26, 2013 - ALPCO

Herpes Solution Provider, Viradux Research Announces JV Partnership

A new development in the war against genital and oral herpes. - April 26, 2013 - viradux

New Efficient Reagents for mRNA Transfection in Classic and Stem Cells

OZ Biosciences SAS, specialized in the development of innovative transfection technologies is delighted to announce the launching of new mRNA transfection Reagents : RmesFect™ and RmesFect™ Stem. - April 25, 2013 - OZ Biosciences

YaxinBio Launches 2 New Products: Enterokinase and V8 Protease

Shanghai Yaxin Biotechnology Co., Ltd. offers two new recombinant proteins. Recombinant Bovine enterokinase, also known as enteropeptidase, is a specific protease used for tag removal, while V8 Protease (Endoproteinase GluC) is highly important for protein structure and sequence... - April 23, 2013 - Shanghai Yaxin Biotechnology Co. Ltd.

Colorado BioScience Association Releases 10th Anniversary Edition of Bioscience Colorado Magazine

10 years of supporting the bioscience industry in Colorado: Then, Now, The Future. - April 22, 2013 - Colorado BioScience Association

USDA Research: Hidrox Exhibits Superior Bactericidal Activity Against Deadly Foodborne Pathogens

A recent USDA study about the bactericidal activity of health-promoting food-derived powders, confirms that Hidrox exerts superior activity against some of today’s major foodborne pathogens: deadly micro-organisms such as Escherichia Coli; Listeria monocytogens; Salmonella enterica and Staphylococcus aureus. - April 15, 2013 - Creagri, Inc.

Eye Doctor Finds Impressive Vision Improvements from Stem Cell Treatment Reports MD Stem Cells

Post-operative visual acuity significantly improved following stem cell treatment for Macular Degeneration according to an independent Optometrist in California. - April 12, 2013 - MD Stem Cells

Virtual Model of Novel Cancer Target Developed

Plebiotic and Pharmacellion Complete Research Project on an in silico Molecular Modelling and Molecular Dynamics Model of Na K ATPase. - April 12, 2013 - Ventac Partners

System Modeling, Simulation, and Design Exploration

Ricardo Software and Red Cedar Technology (RCT) announced a partnership today whereby Ricardo will embed the industry-leading design system exploration technology from RCT into their new vehicle driveline system modeling & simulation tool, called IGNITE. “The key objective of creating... - April 10, 2013 - Red Cedar Technology

Houston Bariatric Practice Hits Surgery Milestone: 100th SPIDER ® Sleeve

Gastric sleeve weight-loss surgery patients report satisfaction with lack of visible scars, recovery and comfort. - April 10, 2013 - TransEnterix

Upcoming Drug Safety Training Opportunities

Don’t Miss Two New Interactive Drug Safety Training Sessions by Dr. Michael J. Klepper, Global Pharmacovigilance Expert, Coming This Spring - April 09, 2013 - Drug Safety Navigator, LLC

Organomation Unveils New State of the Art Website

This latest version of the company’s homepage will provide enhanced customer support and a brand new online store. - March 28, 2013 - Organomation

Cytocentrics is Proud to Announce the Appointment of SciPro as Their New Distribution Partner

Cytocentrics Bioscience GmbH, inventors of Cytocentering technology for automated patch clamp, is proud to announce the appointment of SciPro Inc. as their distribution partner for the CytoPatch2 in North America. - March 28, 2013 - Cytocentrics

ALPCO Expands Product Offering with Addition of Flow Cytometry Reagents

After over twenty years of providing immunoassay kits worldwide, ALPCO has added flow cyometry reagents to their product offering. - March 25, 2013 - ALPCO

MD Stem Cells - Macular Degeneration Patient Continues to Improve Following Stem Cell Treatments

Married for 72 years, patient’s husband confirms positive visual results are continuing for his wife following stem cell treatment for AMD. - March 23, 2013 - MD Stem Cells

Stevens Students Win People’s Choice Award in National Academy of Engineering Ethics Contest

A team of undergraduate students from Stevens Institute of Technology have won the People’s Choice Award in the nationwide National Academy of Engineering Ethics Video Contest for their investigation of nuclear energy as a sustainable power source. With the strong support of the Stevens community, the video garnered an impressive lead in “Likes” on Facebook. - March 23, 2013 - Stevens Institute of Technology

SFL Appoints Advisory Board

SFL announces details of its Advisory Board. - March 22, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd

F2G Ltd Appoints Ian Nicholson as Chief Executive Officer

F2G Ltd, the UK-based antifungal drug discovery and development company, today announced the appointment of Ian Nicholson to the position of CEO and to the Board of Directors. - March 20, 2013 - F2G Ltd

Arbovax Completes Successful Pre-Clinical Trial of Tetravalent Dengue Vaccine

Successful Pre-Clinical Tests Support Vaccine Platform, New Injection Protocol - March 19, 2013 - Arbovax Inc

Stevens Professor Joins Open Source Effort to Develop Low-Cost Drugs

Professor A.K. Ganguly of the Department of Chemistry, Chemical Biology & Biomedical Engineering at Stevens Institute of Technology is contributing his expertise and passion to the Council of Scientific and Industrial Research (CSIR) Open Source Drug Discovery initiative. Dr. Ganguly is focusing on new treatments for malaria and tuberculosis, which are causing millions of deaths while several drugs used to cure these diseases no longer work because of the appearance of resistant strains. - March 16, 2013 - Stevens Institute of Technology

The Jon Block Group to Participate in 2013 AAOS Annual Meeting

The Jon Block Group announced they will be participating in the 2013 annual meeting of the American Academy of Orthopaedic Surgeons, taking place in Chicago from March 19-23, 2013. The Group will be meeting with several orthopedic firms to discuss clinical strategies specifically associated with... - March 13, 2013 - Jon Block Group

Bioo Scientific Launches Kit for Affordable Screening of Enrofloxacin Contamination in Seafood

Bioo Scientific’s just released the MaxSignal® Enrofloxacin ELISA Test Kit to rapidly screen fish and shrimp for enrofloxacin and ciprofloxacin. - March 11, 2013 - Bioo Scientific

Promoters for Improved Protein & Biopharmaceutics Production in Mammalian Cells

Synpromics Ltd, the synthetic promoter company, announces the award by the Technology Strategy Board, the UK’s innovation agency, of an over £240,000 grant under the TSB’s Synthetic Biology initiative to a consortium led by Synpromics and also including Genabler Ltd and the University of Edinburgh’s SynthSys Centre for Synthetic and Systems Biology. - March 09, 2013 - Synpromics Ltd

GoldBio Launches New Product Line: Growth Factors and Stem Cell Reagents

Today in an email to customers, Bart Saracino, Marketing Director, announced the newest line of research products from Gold Biotechnology, Inc.: Growth Factors and Stem Cell Reagents. - March 07, 2013 - Gold Biotechnology, Inc

GenWay Biotech Names Dr. Ruben Flores-Saaib Vice President of Custom and Catalog Services

GenWay Biotech announces Ruben Flores-Saaib, PhD as Vice President of Custom and Catalog Services assuming responsibilities for the Company's custom services and catalog business operating activities. - March 06, 2013 - GenWay Biotech

The CytoPatch™2: Faster, Cheaper, and More Powerful

Cytocentrics Bioscience GmbH, inventors of Cytocentering technology for automated patch clamp, is proud to announce the release of the second generation GLP compliant CytoPatch™ instrument, the CytoPatch2. - March 06, 2013 - Cytocentrics

Acoustics Expert Dr. Prasad Gives Keynote Presentation at International Conference

Professor Marehalli Prasad advocates better design to reduce environmental noise. - March 02, 2013 - Stevens Institute of Technology

MMS Set to Expand Disclosure Services with Registry Reporting Software TrialAssure™

MMS Holdings Inc. today announced that it has successfully executed disclosure management services for several clients and is poised to make strides in this area with its proprietary software, TrialAssure™. TrialAssure™ is a workflow management system that supports the reporting of... - March 02, 2013 - MMS Holdings Inc.

SFL Experts to Present and Chair Sessions at the 2013 DIA Annual EuroMeeting

SFL team showcase expertise in Regulatory Affairs, Public Affairs, Legal Services and Medical Communications at DIA EuroMeeting in Amsterdam. - March 01, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd

Ohio State and Biosortia Pharmaceuticals to Join Forces to Discover Anti-Cancer Compounds

The Ohio State University has signed an agreement with Biosortia Pharmaceuticals of Dublin, Ohio to discover new biologically active natural products with potential anti-cancer activity. Potential candidate compounds discovered during the Biosortia-sponsored research project will primarily be tested against human colon cancer assays. The ultimate goal is to obtain lead compounds that can be licensed to and developed by pharmaceutical companies through Biosortia’s pharmaceutical relationships. - February 28, 2013 - Biosortia Pharmaceuticals

Recent Headlines Within Biotechnology

Recent Headlines
Within Biotechnology